Gregory R Bluemling Selected Research

molnupiravir

1/2023	The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N4-Hydroxycytidine (EIDD-1931) in a mouse model of lethal Ebola virus infection.
1/2021	SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801.
1/2020	An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.
10/2019	Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gregory R Bluemling Research Topics

Disease

10	Infections 03/2024 - 12/2016
3	COVID-19 01/2022 - 01/2021
1	Ebola Hemorrhagic Fever 01/2023
1	Weight Loss (Weight Reduction) 01/2023
1	Muscular Diseases (Myopathy) 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Viremia 01/2020
1	Chronic Hepatitis B 01/2020
1	Virus Diseases (Viral Diseases) 12/2019
1	Alphavirus Infections 11/2019
1	Human Influenza (Influenza) 10/2019
1	Leishmaniasis 01/2017
1	Zika Virus Infection 01/2017

Drug/Important Bio-Agent (IBA)

5	Antiviral Agents (Antivirals)IBA 01/2023 - 12/2016
4	molnupiravirIBA 01/2023 - 10/2019
3	ProdrugsIBA 01/2023 - 10/2019
2	4'-fluorouridineIBA 03/2024 - 05/2021
2	N(4)-hydroxycytidineIBA 01/2023 - 11/2019
2	CytokinesIBA 01/2021 - 01/2017
2	Ribavirin (Virazole)FDA LinkGeneric 12/2019 - 12/2016
2	VaccinesIBA 01/2017 - 12/2016
1	ChemokinesIBA 01/2021
1	Interferon Type IIBA 01/2021
1	Hepatitis B virus P proteinIBA 01/2020
1	clevudineIBA 01/2020
1	Fluorouracil (Carac)FDA LinkGeneric 12/2019
1	NucleosidesIBA 12/2019
1	Virulence Factors (Pathogenicity Factors)IBA 01/2017
1	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2017

Therapy/Procedure

4	Therapeutics 01/2022 - 10/2019
1	Self Administration (Administration, Self) 01/2023
1	Withholding Treatment 01/2020